Hematology TimesKRD appears more active, less safe than KCD in newly diagnosed MMJuly 25, 2017Multiple Myeloma
Hematology TimesHigh ORR with sequential regimen in CLLJuly 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeSenate parliamentarian upends GOP hopes for health billJuly 24, 2017Business of MedicinePractice Management
Oncology Practice5 ways White House can use its muscle to undercut ObamacareJuly 24, 2017Business of MedicinePractice Management
Hematology TimesCHMP recommends midostaurin for FLT3+ AML, SMJuly 23, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesCHMP recommends new indication for obinutuzumabJuly 22, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Oncology PracticePhysician compensation growing but at a slightly slower paceJuly 21, 2017Business of MedicinePractice Management
Hematology TimesModified, CB-derived NK cells target CLL and BLJuly 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesAYA cancer survivors struggle with social functioningJuly 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Hematology TimesFDA grants orphan designation to gilteritinib in AMLJuly 21, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsPembrolizumab takes on r/r PMBCLJuly 20, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsAllele-matching in cord blood transplant yields better survivalJuly 20, 2017Bleeding DisordersCellular TherapyAnemia
Hematology NewsAvelumab induces response in Hodgkin lymphoma after failed allo-SCTJuly 20, 2017Hodgkin LymphomaLymphoma & Plasma Cell DisordersImmuno-oncology
